FLURANDRENOLIDE; NEOMYCIN SULFATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for flurandrenolide; neomycin sulfate and what is the scope of patent protection?
Flurandrenolide; neomycin sulfate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for FLURANDRENOLIDE; NEOMYCIN SULFATE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
DailyMed Link: | FLURANDRENOLIDE; NEOMYCIN SULFATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FLURANDRENOLIDE; NEOMYCIN SULFATE
US Patents and Regulatory Information for FLURANDRENOLIDE; NEOMYCIN SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | CORDRAN N | flurandrenolide; neomycin sulfate | OINTMENT;TOPICAL | 050345-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | CORDRAN N | flurandrenolide; neomycin sulfate | CREAM;TOPICAL | 050346-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |